Dasatinib population pharmacokinetics in patients with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (ph plus all)

被引：0

作者：

Dai, Guowei ^{[1
]}

Roy, Amit ^{[1
]}

Mandava, Mohan ^{[1
]}

Blackwood-Chirchir, Anne ^{[1
]}

Luo, Roger ^{[1
]}

Wu, Chiyuan ^{[1
]}

Pfister, Marc ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Princeton, NJ 08543 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 46卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

100

引用

页码：1085 / 1085

页数：1

共 50 条

[21] Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia [J].

Sakamaki, Hisashi ;

Ishizawa, Ken-ichi ;

Taniwaki, Masafumi ;

Fujisawa, Shin ;

Morishima, Yasuo ;

Tobinai, Kensei ;

Okada, Masaya ;

Ando, Kiyoshi ;

Usui, Noriko ;

Miyawaki, Shuichi ;

Utsunomiya, Atae ;

Uoshima, Nobuhiko ;

Nagai, Tadashi ;

Naoe, Tomoki ;

Motoji, Toshiko ;

Jinnai, Itsuro ;

Tanimoto, Mitsune ;

Miyazaki, Yasushi ;

Ohnishi, Kazunori ;

Iida, Shinsuke ;

Okamoto, Shinichiro ;

Seriu, Taku ;

Ohno, Ryuzo .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (03) :332-341

[22] Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia [J].

Hisashi Sakamaki ;

Ken-ichi Ishizawa ;

Masafumi Taniwaki ;

Shin Fujisawa ;

Yasuo Morishima ;

Kensei Tobinai ;

Masaya Okada ;

Kiyoshi Ando ;

Noriko Usui ;

Shuichi Miyawaki ;

Atae Utsunomiya ;

Nobuhiko Uoshima ;

Tadashi Nagai ;

Tomoki Naoe ;

Toshiko Motoji ;

Itsuro Jinnai ;

Mitsune Tanimoto ;

Yasushi Miyazaki ;

Kazunori Ohnishi ;

Shinsuke Iida ;

Shinichiro Okamoto ;

Taku Seriu ;

Ryuzo Ohno .

International Journal of Hematology, 2009, 89 :332-341

[23] Phase II study of combination of the HyperCVAD regimen with dasatinib in patients with Philadelphia chromosome (Ph) or BCR-ABL positive acute lymphoblastic leukemia (ALL) and lymphoid blast phase chronic myeloid leukemia (CML-LB) [J].

Ravandi, Farhad ;

Thomas, Deborah ;

Kantarjian, Hagop ;

Faderl, Stefan ;

Koller, Charles ;

Brown, Devri ;

Garris, Rebecca ;

Borthakur, Gautam ;

Burger, Jan ;

Kebriaei, Partow ;

Jorgensen, Jeffrey ;

Jones, Dan ;

Cortes, Jorge ;

O'Brien, Susan .

BLOOD, 2007, 110 (11) :828A-828A

[24] PONATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA [J].

Narayanan, V. ;

Pollyea, D. A. ;

Gutman, J. A. ;

Jimeno, A. .

DRUGS OF TODAY, 2013, 49 (04) :261-269

[25] Philadelphia Positive Acute Lymphoblastic Leukemia (Ph plus ALL), Tawam Experience [J].

Alam, Arif ;

al Qawasmeh, Khaled ;

Kanbar, Jihad ;

Syed, Masood H. ;

Lal, Amar ;

Hussain, Sabir ;

Osman, Hani Y. ;

Kristensen, Jorgen .

BLOOD, 2015, 126 (23)

[26] Multivariate Analyses of the Clinical and Molecular Parameters Associated with Efficacy and Safety in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) Treated with Ponatinib in the PACE Trial [J].

Mauro, Michael J. ;

Cortes, Jorge E. ;

Kim, Dong-Wook ;

Pinilla-Ibarz, Javier ;

le Coutre, Philipp ;

Paquette, Ronald ;

Chuah, Charles ;

Nicolini, Franck E. ;

Apperley, Jane ;

Khoury, H. Jean ;

Talpaz, Moshe ;

DiPersio, John F. ;

DeAngelo, Daniel J. ;

Abruzzese, Elisabetta ;

Rea, Delphine ;

Baccarani, Michele ;

Muller, Martin C. ;

Gambacorti-Passerini, Carlo ;

Wong, Stephane ;

Dorer, David J. ;

Knickerbocker, Ronald Keith ;

Rivera, Victor M. ;

Clackson, Tim ;

Turner, Christopher D. ;

Haluska, Frank G. ;

Guilhot, Francois ;

Deininger, Michael W. ;

Hochhaus, Andreas ;

Hughes, Timothy ;

Goldman, John M. ;

Shah, Neil ;

Kantarjian, Hagop M. .

BLOOD, 2012, 120 (21)

[27] Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [J].

Cerchione, Claudio ;

Locatelli, Franco ;

Martinelli, Giovanni .

FRONTIERS IN ONCOLOGY, 2021, 11

[28] Update of Olverembatinib (HQP1351) Overcoming Ponatinib and/or Asciminib Resistance in Patients (Pts) with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) [J].

Jabbour, Panelelias ;

Kantarjian, Hagop M. ;

Koller, Paul B. ;

Jamy, Omer ;

Oehler, Vivian G. ;

Lomaia, Elza ;

Hunter, Anthony M. ;

Uspenskaya, Olga ;

Samarina, Svetlana ;

Mukherjee, Sudipto ;

Baer, Maria R. ;

Zherebtsova, Vera ;

Shuvaev, Vasily ;

Turkina, Anna ;

Davydkin, Igor ;

Cortes, Jorge ;

Guo, Huanshan ;

Chen, Zi ;

Fu, Lei ;

Wang, Hengbang ;

Jiang, Lixin ;

Wang, Cunlin ;

Yang, Dajun ;

Zhai, Yifan .

BLOOD, 2023, 142

[29] Phase II Study of Combination of hyperCVAD with Dasatinib in Frontline Therapy of Patients with Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) [J].

Ravandi, Farhad ;

Thomas, Deborah ;

Kantarjian, Hagop ;

Faderl, Stefan ;

Koller, Charles ;

Dara, Samuel ;

Garris, Rebecca ;

Kebriaei, Partow ;

Borthakur, Gautam ;

Wierda, William ;

Burger, Jan ;

Cortes, Jorge ;

O'Brien, Susan .

BLOOD, 2008, 112 (11) :1005-1005

[30] Phase II study of combination of the hyperCVAD regimen with dasatinib in patients (pts) with newly diagnosed Philadelphia chromosome positive (Ph plus ) acute lymphoblastic leukemia (ALL) [J].

Ravandi, F. ;

Faderl, S. ;

Thomas, D. A. ;

Brown, D. ;

Garris, R. ;

Borthakur, G. ;

Ferrajoli, A. ;

Cortes, J. E. ;

Kantarjian, H. M. ;

O'Brien, S. M. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →